Loading...
Marstacimab
proveedor
Abbexareference
abx831489Tested Applications
ELISA, WBreactivity
Humanstatus
This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications (RUOclonality
MonoclonalDescripción
Marstacimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TFPI, Marstacimab is a fully human monoclonal antibody that binds to and neutralizes TPFI activity and is under development for treatment of hemophilia. Marstacimab is a laboratory-engineered monoclonal antibody designed to treat hemophilia A and B patients, with or without inhibitors. It works by blocking and effectively preventing TFPI from performing the anticoagulant function that it naturally carries out in the human body.
Características del producto
category
Biosimilars
host
Human
clonality
Monoclonal
reactivity
Human
immunogen target
TFPI
host
Human
isotype
IgG1 Lambda
conjugation
Unconjugated
form
Liquid
tested applications
ELISA, WB
size 1
100 µg
size 2
1 mg
expression
Recombinant
purity
> 95%
purification
Purified from cell culture supernatants by Protein A/G chromatography.
buffer
0.01 M PBS. pH 7.4.
storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
dry ice
No
availability
Shipped within 7-12 working days.
alias
Biosimilars
note
CAS Number 1985638-39-8
Quizá le pueda interesar
Goat MAP28 ELISA Kit
proveedor
FineTestreference
EG0012reactivity
goatstatus
RUOPrecio a consultar
Ver másHRP conjugated Streptavidin
proveedor
FineTestreference
FNSA-0001Tested Applications
ELISA, WBstatus
RUOPrecio a consultar
Ver másHRP conjugated Goat Anti-Mouse FC
proveedor
FineTestreference
FNSA-0002Tested Applications
ELISA, WBreactivity
mousestatus
RUOPrecio a consultar
Ver más